Plant-Based Vaccines Market 2023 – Market Brief Analysis, Market Size, Top Leading Companies, Segmentation | Sanofi Pasteur SA, GlaxoSmithKline plc., British American Tobacco PLC, ICON Plc., Agenus Inc.

Plant-Based Vaccines Market

The Plant-Based Vaccines Global Market Report 2023, provides comprehensive information on the plant-based vaccines market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The Plant-Based Vaccines Market’s Growth:

The global market for plant-based vaccines is poised for substantial growth, projected to elevate from $1.38 billion in 2022 to an estimated $1.52 billion in 2023, reflecting a noteworthy compound annual growth rate (CAGR) of 10.5%. However, the landscape is not immune to external factors, as the Russia-Ukraine conflict has cast a shadow on the world’s economic resurgence post-COVID-19. This geopolitical strife has catalyzed economic sanctions, elevated commodity prices, and ushered in disruptions across supply chains, instigating inflationary pressures on goods and services globally. Despite these challenges, the plant-based vaccines market is anticipated to burgeon further, reaching an estimated $2.24 billion by 2027, sustained by a CAGR of 10.1%.

Get A Free Sample Of The Report (Includes Graphs And Tables):

The prevailing trend in the plant-based vaccine market is product innovation, a pivotal development embraced by leading companies seeking to fortify their market presence. Notably, industry giants such as Medicago Inc., a prominent Canadian biopharmaceutical firm, and GSK PLC, a distinguished UK-based pharmaceutical and biotechnology powerhouse, have spearheaded groundbreaking initiatives. A landmark moment occurred in February 2022 when the collaborative efforts of Medicago Inc. and GSK PLC culminated in Health Canada’s approval of COVIFENZ, a revolutionary COVID-19 vaccine. COVIFENZ stands as the inaugural plant-based virus-like particles [VLP], recombinant, adjuvanted vaccine for combating coronavirus disease, heralding a new era in vaccine technology. Employing the cutting-edge coronavirus-like particle (CoVLP) technology, COVIFENZ is distinguished by its composition, featuring recombinant spike (S) glycoproteins meticulously crafted into virus-like particles (VLPs). This pioneering approach underscores the industry’s commitment to advancing vaccine efficacy and safety through innovative plant-based solutions.

The plant-based vaccines market is segmented:

1) Plant-Based Vaccines Market By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types

2) Plant-Based Vaccines Market By Source: Tobacco Plant, Maize, Potato, Other Sources

3) Plant-Based Vaccines Market By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications

Top Major Players

Sanofi Pasteur SA

GlaxoSmithKline plc.

British American Tobacco PLC


Agenus Inc.

North America was the largest region in the plant-based vaccines market in 2022.

The table of contents in TBRC’s plant-based vaccines market report includes:

1. Executive Summary

2. Plant-Based Vaccines Market Characteristics

3. Plant-Based Vaccines Market Trends And Strategies

4. Plant-Based Vaccines Market – Macro Economic Scenario


32. Global Plant-Based Vaccines Market Competitive Benchmarking

33. Global Plant-Based Vaccines Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Plant-Based Vaccines Market

35. Plant-Based Vaccines Market Future Outlook and Potential Analysis

36. Appendix

List Of Tables

Table 1: Global Historic Market Growth, 2017-2022, $ Billion
Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3: Global Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4: Global Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5: Global Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion


Table 74: Sanofi Pasteur SA Financial Performance
Table 75: GlaxoSmithKline plc. Financial Performance
Table 76: British American Tobacco PLC Financial Performance
Table 77: ICON Plc. Financial Performance
Table 78: Agenus Inc. Financial Performance

Read Related Reports:

Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:
The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:






Healthcare Blog:

Global Market Model: